| Literature DB >> 31502587 |
Jakub Wąsik1, Tomasz Stołtny1, Jarosław Pasek2, Karol Szyluk3, Michał Pyda4, Alina Ostałowska5, Sławomir Kasperczyk5, Bogdan Koczy1.
Abstract
BACKGROUND Surgical methods in treatment of joint osteoarthritis (OA) aim at meeting the increasing expectations of people with active lifestyles. Ankle joint arthroplasty has been performed increasingly more often as an alternative to arthrodesis. The aim of this study was to compare arthrodesis and arthroplasty in the treatment of ankle osteoarthritis. MATERIAL AND METHODS The study involved 56 patients (45 males and 11 females) aged 21-72 years (mean 51) presenting with end-stage ankle OA: 29 patients (52%) underwent arthroplasty (Group A) and 27 patients (48%) underwent arthrodesis (Group B). Patients underwent surgery between 2004 and 2016 at a single clinical center. The observation period ranged from 6 to 150 months (mean 55 months). To assess the results of surgical treatment, quality of life (Health Assessment Questionnaire-HAQ, 12-Item Short-Form Survey-SF-12) and functional (American Orthopedic Foot & Ankle-AOFAS, Kofoed, Takakura) scores were used. For pain assessment, Visual Analog Scale was used (VAS). RESULTS After the surgery, group A and B had a statistically significant improvement in the joint function and pain relief according to AOFAS (A: 32.6 to 68.2; B: 27.4 to 61.3), Kofoed (A: 31.8 to 68; B: 25.9 to 60.3), Takakura (A: 30.6 to 62.9; B: 25.4 to 49.3), and VAS scores (A: 7.28 to 4.14; B: 7.33 to 3.78) compared with preoperative scores. After the surgery, quality of life scores improved in both groups, for HAQ (A: 0.91 to 0.53; B: 1.34 to 0.56) and for SF-12 (A: 26.6 to 36.8; B: 25.6 to 38.0). CONCLUSIONS The comparison of total ankle arthroplasty and ankle arthrodesis in treatment of end-stage ankle osteoarthritis did not reveal any significant differences.Entities:
Mesh:
Year: 2019 PMID: 31502587 PMCID: PMC6752092 DOI: 10.12659/MSM.915574
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Characteristics of the studied groups (frequency of occurrence).
| Type of treatment | ||||
|---|---|---|---|---|
| Arthroplasty n=29 | Arthrodesis n=27 | |||
| Average | n | Average | n | |
| 93% | 27 | 67% | 18 | |
| Idiopathic arthrosis | 3% | 1 | 26% | 7 |
| Post-traumatic arthrosis | 86% | 25 | 74% | 20 |
| Comorbidities | 10% | 3 | 0% | 0 |
| Rheumatic diseases | 14% | 4 | 15% | 4 |
| Cardiovascular diseases | 17% | 5 | 33% | 9 |
| Respiratory system diseases | 7% | 2 | 4% | 1 |
| Metabolic diseases | 28% | 8 | 15% | 4 |
| Infectious diseases | 0% | 0 | 7% | 2 |
| Mental disorders | 3% | 1 | 4% | 1 |
n – group size.
Scales of functional evaluation of the foot.
| Scale | Type of treatment | p | |||
|---|---|---|---|---|---|
| Arthroplasty | Arthrodesis | ||||
| Average | SD | Average | SD | ||
| n | 29 | n | 27 | ||
| AOFAS before (max 100 points) | 32.6 | 17.1 | 27.4 | 19.7 | 0.294 |
| AOFAS after | 68.2 | 17.2 | 61.3 | 18.7 | 0.160 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| AOFAS difference | 35.6 | 19.9 | 34.0 | 24.8 | 0.787 |
| Kofoed before (max 100 points) | 31.8 | 19.0 | 25.9 | 14.7 | 0.196 |
| Kofoed after | 68.0 | 17.8 | 60.3 | 16.5 | 0.085 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| Kofoed | 36.2 | 22.2 | 34.4 | 23.8 | 0.775 |
| Takakura before (max 100 points) | 30.6 | 15.4 | 25.4 | 18.9 | 0.263 |
| Takakura after | 62.9 | 15.4 | 49.3 | 15.2 | 0.002 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| Takakura difference | 32.4 | 19.3 | 23.9 | 22.4 | 0.136 |
SD – standard deviation; p – significance level; n – group size.
Assessment of quality of life – HAQ scale.
| Scale | Type of treatment | p | |||
|---|---|---|---|---|---|
| Arthroplasty | Arthrodesis | ||||
| Average | SD | Average | SD | ||
| n | 29 | n | 27 | ||
| HAQ before | 0.91 | 0.47 | 1.34 | 0.46 | 0.001 |
| HAQ after | 0.53 | 0.49 | 0.56 | 0.42 | 0.827 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| HAQ difference | 0.38 | 0.37 | 0.78 | 0.46 | <0.001 |
SD – standard deviation; p – significance level; n – group size; HAQ – Health Assessment Questionnaire.
Assessment of quality of life – SF-12 scale.
| Scale | Type of treatment | p | |||
|---|---|---|---|---|---|
| Arthroplasty | Arthrodesis | ||||
| Average | SD | Average | SD | ||
| n | 29 | n | 27 | ||
| SF-12 before (PCS) | 26.6 | 7.29 | 25.6 | 6.76 | 0.591 |
| SF-12 after (PCS) | 36.8 | 9.41 | 38.0 | 9.54 | 0.631 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| SF-12 difference (PCS) | 10.2 | 9.95 | 12.4 | 10.3 | 0.411 |
| SF-12 before (MCS) | 43.3 | 9.74 | 35.7 | 13.4 | 0.014 |
| SF-12 after (MCS) | 47.4 | 9.25 | 42.9 | 12.0 | 0.119 |
| Comparison before and after surgery | p=0.012 | p<0.001 | |||
| SF-12 difference (MCS) | 4.08 | 7.68 | 7.21 | 8.86 | 0.163 |
SD – standard deviation; p – significance level; n – group size; SF-12 – 12-Item Short-Form Survey; PCS – Physical Health Summary Scales; MCS – Mental Health Summary Scales.
Visual analog scale for pain assessment (VAS).
| Scale | Type of treatment | p | |||
|---|---|---|---|---|---|
| Arthroplasty | Arthrodesis | ||||
| Average | SD | Average | SD | ||
| n | 29 | n | 27 | ||
| VAS before surgery | 7.28 | 1.58 | 7.33 | 1.44 | 0.888 |
| VAS after rehabilitation | 4.14 | 2.21 | 3.78 | 2.33 | 0.553 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| VAS difference | −3.28 | 2.76 | −3.56 | 2.59 | 0.698 |
| VAS before surgery | 7.28 | 1.58 | 7.33 | 1.44 | 0.888 |
| VAS during last follow-up visit | 3.55 | 1.88 | 2.81 | 2.40 | 0.205 |
| Comparison before and after surgery | p<0.001 | p<0.001 | |||
| VAS difference | −3.72 | 2.56 | −4.52 | 2.71 | 0.264 |
SD – standard deviation; p – significance level; n – group size.
Complications after surgery in the examined groups of patients.
| Scale | Type of treatment | p | |||
|---|---|---|---|---|---|
| Arthroplasty | Arthrodesis | ||||
| Average | SD | Average | SD | ||
| n | 29 | n | 27 | ||
| Periodic pain during the observation period | 48% | 14 | 59% | 16 | 0.420 |
| Patient subjective feeling of a reduced ROM | 17% | 5 | 4% | 1 | 0.108 |
| Edema during the observation period | 14% | 4 | 26% | 7 | 0.263 |
| Instability during the observation period | 17% | 5 | 0% | 0 | 0.024 |
| Prolonged healing of the postoperative wound | 3% | 1 | 0% | 0 | 0.353 |
n – group size; p – significance level.